Issue 29
Get instant access to latest e-book

latest news


Dec 2017

Cyclenium Pharma Announces Drug Discovery Collaboration Agreement with Ono Pharmaceutical

Cyclenium Pharma Inc an emerging pharmaceutical company specializing in the discovery and development of novel therapeutic agents based on their proprietary macrocyclic chemistry announced today the signing of a drug discovery collaboration agreement with Ono Pharmaceutical Co Ltd a leading Japanese pharmaceutical research and development…


Dec 2017

Daiichi Sankyo and Puma Biotechnology Announce Research Collaboration with Major Cancer Center in HER2-Mutated Cancer

Daiichi Sankyo Company Limited and Puma Biotechnology Inc have announced a preclinical research collaboration with Memorial Sloan Kettering Cancer Center MSK to explore the combination of Daiichi Sankyos investigational antibody drug conjugate DS and Puma Biotechnologys irreversible panHER tyrosine kinase inhibitor neratinib NERLYNX in HERmutated…


Dec 2017

Medigene Collaborates with RXi Pharmaceuticals to Further Sharpen its Therapeutic T cells

RXi Pharmaceuticals Corporation announced today that it has entered into a research collaboration with Medigene AG MDG Frankfurt Prime Standard TecDAX to explore potential synergies of using RXis selfdelivering RNAi technology sdrxRNA in combination with Medigenes recombinant TCRs to develop modified T cells with enhanced…

press releases


Dec 2017

Omeros Corporation Announces FDA Approval of OMIDRIA® for Use in Pediatric Patients

Omeros Corporation a commercialstage biopharmaceutical company committed to discovering developing and commercializing smallmolecule and protein therapeutics for largemarket as well as orphan indications targeting inflammation complementmediated diseases and disorders of…


Dec 2017

Tremeau and FDA Agree on Phase III Plan for Rofecoxib as a Non-Opioid Pain Treatment for Hemophilic Arthropathy

Tremeau Pharmaceuticals Inc Tremeau a new pharmaceutical company focused on providing nonopioid pain treatments for rare diseases announced today that it has recently gained agreement with the US Food and…


Dec 2017

Ardelyx Announces License Agreement with Shanghai Fosun Pharmaceutical Industrial Development Company Limited for Tenapanor in China

Ardelyx Inc announced that the company has entered into a license agreement with Shanghai Fosun Pharmaceutical Industrial Development Company Limited Fosun Pharma providing Fosun Pharma with the exclusive rights to…

Events


Dec 2017

Gut-Brain Axis Summit 2017

Hanson Wade
Kimpton Sir Francis Drake Hotel


Dec 2017

7th ISN-EMAN Update in Nephrology

MCI Middle East
Intercontinental Festival City Dubai


  • 4

    Parenteral Preparations

    INTRODUCTION Parenteral preparations are defined as solutions suspensionsemulsions for injection or infusion powders for injection or infusion gels for injecti..

Knowledge Bank

  • Interviews

    Datwyler Pharma Packaging

    Senior Manager Global Scientific Affairs
    Renaud Janssen PhD is the Senior Manager of Global Scientific Affairs at Datwyler Pharma Packaging He frequently presents on international conferences on subjects related to elastomeric and aluminiumplastic closures for pharmaceutical applications Re..

  • Articles

    Nanotherapeutic Intervention in Cancer Disease

    Introduction Cancer is second most prevalent and lethal disease after cardiovascular disorder despite of advances in tumor biology research and chemotherapy The nanotechnology tremendously growing with due advances in nanomedicine and drug delivery system The mantra of nanotherapy in cancer based on right medicine right dose right target right time of exposure patient safety…

  • Techno Trends

    Sanofi and Regeneron’s Cemiplimab Receives FDA "Breakthrough Designation"

    Sanofi and Regeneron announced that Cemiplimab REGN has received FDA Breakthrough Therapy Designation for Advanced Cutaneous Squamous Cell Carcinoma Cemiplimab is an investigational human monoclonal antibody targeting PD It would be used to treat adults with metastatic cutaneous squamous cell carcinoma CSCC and adults with locally advanced and unresectable CSCC the second deadliest skin cancer after melanoma Preliminary results for…

Editorial Section

  • Strategy

    China Biopharma

    China today according to our recent studies is actively growing its domestic industry not only to support its huge domestic demand for high quality therapeutics but also to develop an export market capability The industry is making progress with substantial…

  • Clinical Trials

    Patient Recruitment

    To address the challenges faced in patient recruitment and retention in clinical trials innovative technologies are being utilised in AsiaPacific as well as other regions to optimise the processes involved From patient matching to improving the consent process technology has…

  • Manufacturing

    Continuous Manufacturing

    The urgent need to dramatically improve efficiency and productivity within the pharmaceutical manufacturing sector is in the state of flux With the US FDAs push for moving the pharmaceutical industry into st century reality of…

  • Expert Talk

    The Asian Healthcare Market

    The Asian market is growing rapidly and along with this expansion comes the issue of drug counterfeiting Bernd offers his insight into the key trends affecting this market and what regulatory authorities are expecting manufacturers…